Principal Toxicologist jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alcon · 4 days ago

Principal Toxicologist

Alcon is a global leader in eye care, dedicated to helping people see brilliantly. The Principal Toxicologist will provide scientific and strategic input for the nonclinical safety assessment of pharmaceutical and medical device products throughout their development.

Health CareManufacturingMedical Device
badNo H1Bnote

Responsibilities

Lead development and execution of phase-appropriate nonclinical safety assessment program strategies with integrated project plans including milestones, timelines, and budgets
Review, summarize and integrate complex datasets across all nonclinical safety disciplines (toxicology, safety pharmacology, genotoxicity, developmental & reproductive toxicology, immunotoxicology, etc) for project teams, portfolio management, senior leaders, internal/external partners and/or scientific groups
Critically evaluate and interpret results of nonclinical safety assessment studies and contribute to authoring of global regulatory documents (INDs, NDAs, IBs, etc)
Support phase-appropriate control strategies for impurities, excipients, residual solvents, and raw materials including application of computational toxicology, preparation of risk assessment/toxicology monographs, determination of risk-based limits (e.g., PDEs, ADIs)
Collaborate with internal stakeholders and external partners (CROs, consultants) to ensure timely and high-quality execution of nonclinical deliverables
Work closely with cross-functional teams to provide conduct and lead toxicological risk assessments for new and existing medical devices, components, and materials. This includes creating Biological Evaluation Plans (BEPs) and Biological Evaluation Reports (BERs) in accordance with ISO 10993 and responding to questions from regulatory agencies
Identify and assess business/technical project risks and recommend/influence contingency plans for risk mitigation. Apply technical expertise to solve complex biocompatibility problems as related to the ISO 10993 standards and regulatory authority requirements for product safety

Qualification

PhD in ToxicologyNonclinical safety assessmentToxicology principlesRegulatory requirementsBiocompatibility evaluationsData analysisADME conceptsMicrosoft OfficeCommunication skillsOrganizational skillsInterpersonal skills

Required

Bachelor's Degree or Equivalent years of directly related experience (or high school +13 yrs; Assoc.+9 yrs; M.S.+2 yrs; PhD+0 yrs)
The ability to fluently read, write, understand and communicate in English
5 Years of Relevant Experience

Preferred

PhD in Toxicology or a related discipline (e.g., Pharmacology, Biomedical Sciences)
Relevant experience in pharmaceutical and/or medical device development (industry, postdoctoral, or equivalent)
Strong understanding of toxicology principles and regulatory requirements for nonclinical safety assessment
Excellent written and verbal communication skills
Knowledge of, and experience with, nonclinical small molecule development, drug metabolism, ADME concepts, pharmacokinetics, safety/toxicology, pharmacodynamic and bioanalytical principles
Practical knowledge of the laboratory methods and analytical techniques associated with medical device and/or combination product biocompatibility and chemical characterization evaluations
Demonstrated strong decision making and complex data analysis and interpretation relating to drug development
Strong communication, organizational and interpersonal skills to work within a matrix setting
Knowledgeable of pertinent sections of REACH, the EU MDR, and Proposition 65 (hazardous substances regulations) as well as ICH and FDA Guidance Documents (e.g., Threshold of Toxicological Concern and Use of ISO 10993-1, etc.)
Proficient with statistics and Microsoft suite of office applications

Benefits

Health
Life
Retirement
Flexible time off
And much more

Company

Alcon specializes in developing and manufacturing innovative medicines and devices to serve the cycle of eye care.

Funding

Current Stage
Public Company
Total Funding
unknown
2010-12-15Acquired
2002-03-21IPO

Leadership Team

leader-logo
David Endicott
Chief Executive Officer
linkedin
leader-logo
Tim Stonesifer
Chief Financial Officer
linkedin
Company data provided by crunchbase